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Abstract
Background Revision total hip replacement (THR) is
associated with increased blood loss and extended
hospitalization.
Materials and methods We reviewed 146 patients who
underwentrevisionTHR toidentifypredictorsofblood loss,
transfusion requirements, and length of hospitalization.
Results Blood loss was greater with increasing age and in
men. Femoral and dual-component revision and revision of
cemented hip components were also associated with
greater blood loss. Transfusion requirements were greater
in patients who had lower preoperative hemoglobin con-
centration and in patients undergoing dual-component
revision. Length of hospitalization was signiﬁcantly
increased in patients who received transfusion but less in
patients who underwent isolated acetabular-component hip
revision.
Conclusions This study shows signiﬁcantly greater blood
loss in men, older patients, revision surgery of cemented
implants, and dual-component revisions. More complex
revision surgery and preoperative anemia are clearly
associated with increased transfusion requirements and
length of hospitalization. Identiﬁcation and treatment of
patients at higher risk of transfusion may guide likely
transfusion requirements, shorten the length of hospital-
ization, and reduce the overall cost of treatment.
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Introduction
Patients undergoing revision total hip replacement (THR)
are at greater risk of perioperative blood loss, requiring
transfusion [1] and extended length of hospitalization [2],
which can have substantial cost implications. Allogenic
transfusion carries the risk of disease transmission and
immunological reactions and has been shown to increase
the length of hospitalization [3]. Identiﬁcation of patients
potentially requiring transfusion is desirable to improve
blood use and more accurately identify which patients
should receive established pre- and perioperative blood
conservation interventions. In this study we examined the
inﬂuence of variables such as age, gender, preoperative
hemoglobin concentration and type of revision surgery on
blood loss, transfusion rates, and length of hospitalization
following revision THR.
Materials and methods
A retrospective analysis was conducted on 146 patients
who underwent elective revision total hip arthroplasty
(THA) in our unit over a 5-year period. Operations were
performed by four consultant surgeons using various
surgical and anesthetic techniques. The analysis did not
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DOI 10.1007/s10195-010-0105-zspeciﬁcally look into the modes of implant failure and
excluded cases of revision THA for infection or fractures
as well as early revisions for dislocations secondary to
implant malposition. Data were grouped according to the
type of THR component that was revised (acetabular,
femoral, or dual components).
The electronic database was searched, and variables
such as pre- and postoperative hemoglobin concentrations,
patient demographics such as age and gender, type of
revision surgery, transfusion rates, and length of hospi-
talization were recorded. Blood loss was estimated by
measurement of pre- and postoperative hemoglobin con-
centrations (24 h after surgery); the difference between
concentrations was recorded in each case. Anemia was
deﬁned as hemoglobin levels \12 g/dl in women and
\13 g/dl in men [4].
Data were analyzed using statistical software (SPSS
16.0 for Windows—SPSS Inc., Chicago, IL, USA). Pear-
son’s correlation coefﬁcients were calculated to examine
the relationship between blood loss, transfusion require-
ments, length of hospitalization, age, and preoperative
hemoglobin levels. Continuous data were analyzed using
the Student’s t test and categorical data by the Mann–
Whitney U test. Multiple linear regressions were used to
examine the relationship between blood loss, length of
stay, and transfusion rates with the variables analyzed. For
comparing the percentage of patients receiving blood
transfusion in the different subgroups, Fisher’s contingency
table analysis was performed. A P value \0.05 was con-
sidered to be signiﬁcant.
Data were retrieved from case notes and did not involve
direct patient participation. No identiﬁable parameters
were investigated or recorded. The regional ethics com-
mittee authorised the study and advised that informed
consent from patients was not required due to the retro-
spective nature of the analysis.
Results
One hundred and forty-six patients who underwent elective
revision THR surgery were reviewed in this study. Table 1
describes patient characteristics and shows that men
(n = 50) and women (n = 96) were evenly matched for
age.
The average drop in hemoglobin concentration follow-
ing elective revision THR was 4.6 g/dl (32%) in men and
3.5 g/dl (27%) in women (p = 0.021). The preoperative
hemoglobin concentration was, as expected, signiﬁcantly
higher in male patients. No signiﬁcant difference was
observed in the percentage of cases receiving transfusion or
overall transfusion numbers between male and female
patients (Table 1).
Relationship between blood loss and type of THR
component revision
In 23 cases, there was insufﬁcient information in the
electronic database about the components that were revised
during surgery. Therefore, only 123 patients were analyzed
with reference to the type of revised component (Table 2).
Dual-component revision in a hybrid THR was classiﬁed as
cemented, as one of the components by default is
cemented.
Blood loss following acetabular-component revision
(3.3 g/dl) was signiﬁcantly less than dual-component
(4.7 g/dl) (P\0.001) and femoral-component (4.2 g/dl)
(P = 0.048) revisions (Table 3). Patients who underwent
acetabular-component revisions received less transfusions
compared with patients who underwent dual-component
revision (P\0.001). Overall, 33% (n = 21) of patients
who underwent acetabular-component revision received
blood transfusions compared with 42% (n = 5) in femoral-
component revision (P = 0.124) and 73% (n = 35) in
dual-component revision (P\0.001).
Revisions of cemented THR components were associ-
ated with increased blood loss but did not lead to higher
rates of transfusion (Table 4).
Table 1 Characteristics of cases of revision total hip replacement
Male Female P value
Number of cases (n)5 0 9 6 –
Age (years) 67.3 ± 12.2 70.2 ± 11.3 0.555
Preoperative hemoglobin
concentration (g/dl)
14.2 ± 1.36 12.7 ± 1.25 \0.001*
Blood loss (g/dl) 4.6 ± 1.75 3.5 ± 1.64 0.021*
Length of hospitalization
(days)
12.8 ± 9.3 14.9 ± 17.5 0.545
Number of units
transfused (n)
71 188 0.295
Number of patients
transfused (n)
22 (44%) 51 (53%) 0.258
* Statistically signiﬁcant
Table 2 Type of total hip replacement components revised
Components revised Type of implant
Cemented Uncemented
Acetabular component (63) 55 8
Femoral component (12) 11 1
Dual components (48) 43 5
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concentration), age, and preoperative hemoglobin
concentration
Univariate analysis only revealed a signiﬁcant relationship
between blood loss and preoperative hemoglobin concen-
tration (P\0.001) (Table 5).
However, multivariate regression analysis also identiﬁed
age (P = 0.027) as an independent variable with signiﬁ-
cant correlation to blood loss (Table 6).
Relationship between blood transfusion and variables
Sixty-eight of the 146 patients who underwent revision
THR received blood transfusion. Univariate analysis
revealed a signiﬁcant relationship between the number of
blood transfusions and age (P = 0.002), preoperative
hemoglobin concentration (P = 0.022), and blood loss
(P\0.001) (Table 7).
After adjustment for potential confounders in a stepwise
multivariate linear regression analysis, only preoperative
Table 7 Correlation between
transfusion requirements and
variables investigated
* Statistically signiﬁcant
Age Preoperative
hemoglobin
concentration
Blood loss Length of
hospitalization
Number of transfusions
Pearson correlation 0.256* -0.178* 0.346* 0.300*
Signiﬁcance (2-tailed) 0.002 0.022 0.000 0.000
Table 6 Multivariate
regression model for blood loss
* Statistically signiﬁcant
Independent variables Regression coefﬁcient 95% Conﬁdence interval P value
Age (years) 0.162 (0.011) 0.003–0.046 0.027*
Preoperative hemoglobin
concentration (g/dl)
0.540 (0.086) 0.470–0.808 \0.001*
Table 3 Characteristics of
patients undergoing revision
total hip replacement based on
component revision
* Statistically signiﬁcant
Acetabular component
(n = 63)
Femoral component
(n = 12)
Dual component
(n = 48)
Blood loss (g/dl) 3.3 ± 1.29* 4.2 ± 1.29* 4.7 ± 1.92*
Number of cases transfused (n) 21 (33%) 5 (42%) 35 (73%)
Number of transfusions (n) 76 16 123
Length of hospitalization
(days)
10.6 ± 6.3 13.7 ± 7.3 13.0 ± 14.3
Table 4 Characteristics of
patients undergoing revision of
cemented and uncemented total
hip replacement components
* Statistically signiﬁcant
Components revised Cemented
(n = 109)
Uncemented
(n = 14)
P value
Blood loss (g/dl) 4.1 ± 1.73 2.6 ± 1.23 0.001*
Number of cases transfused (n) 54 (49.5%) 5 (36%) 0.703
Number of transfusions (n) 204 12 0.174
Length of hospitalization (days) 12.6 ± 10.5 11.3 ± 6.5 0.570
Table 5 Correlation between
blood loss and variables
investigated
* Statistically signiﬁcant
Age Number of
transfusions
Preoperative
hemoglobin
concentration
Length of
hospitalization
Blood loss
Pearson’s correlation 0.090 0.346* 0.478* 0.022
Signiﬁcance (2-tailed) 0.156 0.000 0.000 0.404
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(P\0.001) remained signiﬁcant (Table 8).
Twenty-four percent of female patients (n = 25) and
20% of male patients (n = 10) were anemic preopera-
tively. Seventy-four percent (n = 19) of female patients
who were anemic preoperatively required allogenic trans-
fusion compared with only 46% in those who were not
anemic (P = 0.01) (Fig. 1). The odds ratio (OR) for an
anemic female patient to receive transfusion was 3.5
compared with a nonanemic patient. In male patients with
preoperative anemia (hemoglobin\13 g/dl), 78% required
transfusion compared with 37% in those who were not
anemic (P = 0.02) (Fig. 2). The OR for an anemic male
patient to receive transfusion was 6.1.
Relationship between length of hospitalization
and variables
A signiﬁcant relationship was observed between length of
hospitalization and age (P = 0.028), number of transfu-
sions (P\0.001), and preoperative hemoglobin levels
(P = 0.029) (Table 9).
Patients older than 70 years who underwent revision
THR spent signiﬁcantly more days in hospital (16.6 days)
compared with younger patients (11.5 days) (P\0.001)
(Fig. 3).
However, multivariate analysis identiﬁed a signiﬁcant
relationship only between length of hospitalization and
blood transfusion (P = 0.006) (Table 10). Transfused
patients had an average increased length of hospital stay of
6 days (17.3 versus 11.1 days, P = 0.006).
Relationship between length of hospitalization
and gender
The average length of hospital stay following elective
revision THR was 14.2 days, with male patients averaging
12.8 days compared with 14.9 days in female patients,
demonstrating no signiﬁcant difference (P = 0.547)
(Table 1).
Relationship between length of hospitalization and type
of THR component revision
The length of hospital stay was shorter in patients who
underwent acetabular-component revision compared with
dual\-component revision (P = 0.006). No signiﬁcant dif-
ference in the length of hospital stay was observed when
Table 8 Multivariate
regression model for transfusion
requirements
* Statistically signiﬁcant
Independent variable Regression coefﬁcient 95% Conﬁdence interval P value
Age (years) 0.021 (.017) -0.13 to 0.054 0.230
Preoperative hemoglobin
concentration (g/dl)
-0.642 (0.157) -0.952 to -0.332 \0.001*
Blood loss (g/dl) 0.752 0.499–1.006 \0.001*
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Fig. 1 Proportions of female patients receiving blood transfusion
based on preoperative hemoglobin level
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Fig. 2 Proportions of male patients receiving blood transfusion based
on preoperative hemoglobin level
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123comparing femoral-component revisions with dual-com-
ponent or acetabular-component revisions or between
cemented and uncemented implants (Table 3 and 4).
Discussion
This study was undertaken to determine what variables
could be predictive of the need for postoperative blood
transfusion and prolonged hospitalization following revi-
sion THA in order to develop a system that ensures
effective use of resources, including blood-conservation
techniques and funding.
Overall, 46% of patients who underwent revision THA
received blood transfusions, which is consistent with the
ﬁndings of Sharma et al. [1] (39–56%) but substantially
lower than the ﬁgures of Phillips et al. [5]o f[90%.
Blood loss
In this study, blood loss was signiﬁcantly greater in men,
older patients, revision of cemented implants, and
dual-component revisions. Grosﬂam et al. [6] shown that
male gender was a signiﬁcant predictor for greater blood
loss following THR. Our analysis concurred with their
ﬁndings, showing that blood loss was signiﬁcantly greater
in men during revision surgery. In revision arthroplasty,
cement and implant removal can be challenging, time-
consuming, and damaging to the remaining host bone [7].
We postulated that removal of well-ﬁxed cement from
bone surfaces at the time of revision surgery was likely to
cause more bleeding compared with removal of unce-
mented components. The postoperative fall in hemoglobin
in our analysis supports this hypothesis. We concurred with
previous studies that dual-component revision is associated
with increased blood loss [8, 9]. Other factors that have
been shown to inﬂuence blood loss during THA include the
use of general anesthesia, American Society of Anesthe-
siologists (ASA) class [6], and patient positioning [10].
Transfusion requirements
Increased transfusion rates correlated with patient age,
preoperative hemoglobin concentration, blood loss, and
dual-component revision surgery. Increased blood loss was
found in men and revisions of cemented implants, but this
did not correspond to higher levels of transfusion.
Increasing age was associated with higher levels of
transfusion. These ﬁndings support previous studies that
identiﬁed age as a signiﬁcant predictive factor for trans-
fusion in patients undergoing elective THA [6, 11, 12]. The
increased transfusion levels in older patients was likely to
be related to their lower preoperative hemoglobin con-
centrations, as after adjustment for confounders, only pre-
operative hemoglobin concentration and blood loss
remained signiﬁcant for transfusion. Preoperative anemia
increased the likelihood of allogenic transfusion by up to
six times. Our results support Feagan et al. [11] and Salido
et al. [13], who investigated transfusion requirements in
patients undergoing elective hip and knee arthroplasty.
Table 9 Correlation between
length of hospitalization and
variables investigated
* Statistically signiﬁcant
Age Number of
transfusions
Preoperative hemoglobin
concentration
Blood loss
Length of hospitalization
Pearson’s correlation 0.169* 0.300* -0.167* 0.022
Signiﬁcance (2–tailed) 0.028 0.000 0.029 0.404
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Fig. 3 Length of hospitalization in relation to patient age
Table 10 Multivariate regression model for length of hospitalization
Independent variable Regression coefﬁcient 95% Conﬁdence interval P value
Age (years) 0.085 (0.117) -0.122 to 0.342 0.348
Preoperative hemoglobin concentration (g/dl) -0.115 (0.970) -3.128 to 0.711 0.215
Number of transfusions (n) 0.282 (0.597) 0.497–2.860 0.006*
Blood loss (g/dl) -0.047 (0.992) -2.382 to 1.545 0.674
* Statistically signiﬁcant
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Prolonged length of hospitalization following revision
THA was found in patients with lower preoperative
hemoglobin concentrations, those receiving blood transfu-
sion, and with increasing patient age. Patients who under-
went isolated acetabular-component revision spent fewer
days in hospital compared with patients who underwent
femoral- or dual-component revision. However, a signiﬁ-
cant statistical difference was only demonstrated when
acetabular-component revisions were compared with dual-
component revisions. The small number of cases (n = 12)
in the femoral-component revision group may have resul-
ted in a failure to observe a true difference (type II error)
when statistical analysis was applied. No association was
identiﬁed between length of hospitalization and gender.
Patients with preoperative anemia have prolonged hos-
pitalization following orthopedic surgery [6, 14–16]. These
patients often require blood transfusions, which is an
important factor in prolonging hospitalization [4, 17]. In
our study, patients who received blood transfusion spent an
additional 6 days in hospital. The cost for a 24-h stay on a
National Hospital Services (NHS) surgical ward is around
£400, increasing to £1,500 per day if surgical complica-
tions require the expertise of the intensive care unit [18].
Patients who received blood transfusions following revi-
sion THA could cost the NHS at least an additional £2,400
on prolonged hospital stay alone. It appears likely that
aggressive treatment of preoperative anemia would reduce
transfusion requirements and costs. Patients who receive
allogenic blood are not only exposed to the risks of blood
transfusion but also spend more days in hospital, which has
health and ﬁnancial implications.
The limitations of this study include the relatively small
sample size. We also lacked information on the type of
revision undertaken on these failed implants, which may
havehadabearingontheresultsofthisstudy.Theestimation
of blood loss was calculated using the pre- and postoperative
hemoglobin concentration. A more accurate method of
estimating blood loss would be using a mathematical model
such as the one devised by Brecher et al. which takes into
account parameters such as blood volume, hematocrit count,
transfusion triggers, and amount of hemodilution performed
[19]. However, we did not have sufﬁcient data in our records
to undertake these calculations.
This study has shown signiﬁcantly greater blood loss in
men, older patients, revision surgery of cemented implants,
and dual-component revisions. More complex revision
surgery and preoperative anemia are clearly associated
with increased transfusion requirements and length of
hospitalization. Identiﬁcation and treatment of patients at
higher risk of transfusion may guide likely transfusion
requirements, shorten the length of hospitalization, and
reduce the overall cost of treatment.
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